NAGE vs UBER · P/E 59, rev $99.6M vs P/E 18, rev $52.02B
Niagen Bioscience, Inc. (NAGE) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the NAGE and UBER stock pages for the full models.
Not investment advice.